Cullinan Therapeutics Inc (CGEM)

Oct 15, 2025

Does Cullinan Therapeutics Inc. qualify in momentum factor screening2025 Key Highlights & Smart Money Movement Alerts - newser.com

Oct 15, 2025

Oct 15, 2025

Visual analytics tools that track Cullinan Therapeutics Inc. performance2025 Volatility Report & Weekly Chart Analysis and Guides - newser.com

Oct 15, 2025

Oct 15, 2025

Is Cullinan Therapeutics Inc. stock a good choice for value investors2025 Performance Recap & Comprehensive Market Scan Insights - newser.com

Oct 15, 2025

Oct 15, 2025

Cullinan Therapeutics Inc. stock prediction for this week2025 EndofYear Setup & Risk Managed Investment Signals - newser.com

Oct 15, 2025

Oct 15, 2025

Volume spikes in Cullinan Therapeutics Inc. stock – what they mean2025 Market Sentiment & Daily Profit Focused Screening - newser.com

Oct 15, 2025

Oct 15, 2025

What momentum shifts mean for Cullinan Therapeutics Inc.Breakout Watch & Advanced Swing Trade Entry Plans - newser.com

Oct 15, 2025

Oct 14, 2025

What makes Cullinan Therapeutics Inc. stock attractive to growth fundsQuarterly Performance Summary & Risk Adjusted Swing Trade Ideas - newser.com

Oct 14, 2025

Oct 13, 2025

Cullinan Therapeutics Cancer Drug Shows Efficacy In Brain Metastases Among Lung Cancer Patients With Certain Mutations - Sahm

Oct 13, 2025

Oct 12, 2025

Taiho Oncology, Cullinan: Zipalertinib 31.3% Intracranial ORR in NSCLC | CGEM Stock News - Stock Titan

Oct 12, 2025

Oct 11, 2025

Cullinan Therapeutics (NASDAQ:CGEM) Major Shareholder Buys $3,593,698.00 in Stock - MarketBeat

Oct 11, 2025

Oct 11, 2025

Lynx1 Capital Management Lp Buys 277,298 Shares of Cullinan Therapeutics (NASDAQ:CGEM) Stock - MarketBeat

Oct 11, 2025

Oct 10, 2025

Lynx1 capital buys Cullinan Therapeutics (CGEM) shares worth $9.8m By Investing.com - Investing.com South Africa

Oct 10, 2025

Oct 10, 2025

Lynx1 capital buys Cullinan Therapeutics (CGEM) shares worth $9.8m - Investing.com

Oct 10, 2025

Oct 10, 2025

Can machine learning forecast Cullinan Therapeutics Inc. recoveryDay Trade & Daily Profit Focused Screening - newser.com

Oct 10, 2025

Oct 10, 2025

How to forecast Cullinan Therapeutics Inc. trends using time series2025 Trade Ideas & Real-Time Chart Breakout Alerts - newser.com

Oct 10, 2025

Oct 10, 2025

Cullinan Therapeutics Inc. stock momentum explainedEarnings Performance Report & Weekly Momentum Stock Picks - newser.com

Oct 10, 2025

Oct 10, 2025

Here's Why We're Watching Cullinan Therapeutics' (NASDAQ:CGEM) Cash Burn Situation - Sahm

Oct 10, 2025

Oct 09, 2025

Cullinan Therapeutics (NASDAQ:CGEM) Receives Sell (E+) Rating from Weiss Ratings - MarketBeat

Oct 09, 2025

Oct 06, 2025

Reversal indicators forming on Cullinan Therapeutics Inc. stock2025 Volatility Report & Verified Entry Point Signals - newser.com

Oct 06, 2025

Sep 29, 2025

Published on: 2025-09-29 10:05:02 - newser.com

Sep 29, 2025

Sep 29, 2025

Cullinan Therapeutics Inc Stock Analysis and ForecastSupport Level Holds & Free Stock Education Platform for New Investors - earlytimes.in

Sep 29, 2025

Sep 28, 2025

What analysts say about Cullinan Therapeutics Inc stockCandlestick Pattern Analysis & Small Budget Wealth Building - earlytimes.in

Sep 28, 2025

Sep 28, 2025

How to use a screener to detect Cullinan Therapeutics Inc. breakoutsQuarterly Market Review & Capital Efficiency Focused Strategies - newser.com

Sep 28, 2025

Sep 26, 2025

How moving averages guide Cullinan Therapeutics Inc. tradingMarket Performance Report & High Accuracy Investment Signals - newser.com

Sep 26, 2025

Sep 26, 2025

Published on: 2025-09-26 16:18:03 - newser.com

Sep 26, 2025

Sep 25, 2025

Multi asset correlation models including Cullinan Therapeutics Inc.July 2025 Highlights & Daily Stock Trend Watchlist - newser.com

Sep 25, 2025

Sep 24, 2025

Cullinan Therapeutics, Inc. $CGEM Shares Bought by Rhumbline Advisers - Defense World

Sep 24, 2025

Sep 23, 2025

Using R and stats models for Cullinan Therapeutics Inc. forecastingLong Setup & Entry Point Confirmation Signals - newser.com

Sep 23, 2025

Sep 23, 2025

BDTX vs. Cullinan Therapeutic: Which EGFR Challenger Is the Better Buy? - sharewise.com

Sep 23, 2025

Sep 22, 2025

Cullinan Therapeutics (NASDAQ:CGEM) Raised to Hold at Zacks Research - MarketBeat

Sep 22, 2025

Sep 22, 2025

Cullinan Therapeutics Hits New 52-Week Low at $6.32 - Markets Mojo

Sep 22, 2025

Sep 22, 2025

Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Receives $26.00 Consensus Price Target from Analysts - MarketBeat

Sep 22, 2025

Sep 21, 2025

Cullinan Therapeutics Hits New 52-Week Low at $5.89 - Markets Mojo

Sep 21, 2025

Sep 21, 2025

Cullinan Therapeutics Hits New 52-Week Low at $6.24 Amidst Major Decline - Markets Mojo

Sep 21, 2025

Sep 21, 2025

using r and stats models for cullinan therapeutics inc. forecastingTrade Volume Report & Weekly Market Pulse Updates - newser.com

Sep 21, 2025